lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
935 rows where filing_year = 2014 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1511586 | RED+BLUE STRATEGIES 95894dfb-5688-4159-9bf7-419d9d6e2581 | Q1 | RED+BLUE STRATEGIES | 400693064 | BLUE CROSS BLUE SHIELD OF MASSACHUSETTS | 2014 | first_quarter | PHA | Issues related to opioid abuse interventions and policies to help curb fraud and abuse, while at the same time improving outcomes for individuals with pain management needs. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2014-04-03T11:35:28.473000-04:00 | |
| 1511597 | AMERICAN COLLEGE OF CLINICAL PHARMACY 390e2540-aa5c-4892-a626-81dd69025cd7 | Q1 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2014 | first_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 145515 | 0 | 0 | 2014-04-03T12:13:31.350000-04:00 | |
| 1511638 | KATE MOSS b0ee7495-59ce-4325-bd4e-93e4714761cc | Q1 | KATE MOSS | 25988 | CVS HEALTH | 2014 | first_quarter | PHA | Issues related to prescription drug abuse and drug supply chain safety. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2014-04-03T13:47:57.277000-04:00 | |
| 1511933 | HEARTLAND SOLUTIONS GROUP, INC. d9b8bbe7-626b-4657-a790-b31ece02f760 | Q1 | HEARTLAND SOLUTIONS GROUP, INC. | 312133 | ZEBRA TECHNOLOGIES CORPORATION | 2014 | first_quarter | PHA | Any and all issues related to barcode, secure identification and real-time location systems. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2014-04-06T16:15:18.437000-04:00 | |
| 1511938 | INJURED WORKERS PHARMACY f5d37e16-6ca6-4ac6-8575-a85abf6f612c | Q1 | INJURED WORKERS PHARMACY | 400765309 | INJURED WORKERS PHARMACY | 2014 | first_quarter | PHA | n/a | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2014-04-07T08:56:20.080000-04:00 | ||
| 1511949 | CYBER SECURITY RESEARCH CONSULTANTS, LLC e4648362-3f9e-4837-9557-9811f348aad3 | Q1 | CYBER SECURITY RESEARCH CONSULTANTS, LLC | 91694 | PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2014 | first_quarter | PHA | Monitoring Drug importation legislation | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2014-04-07T10:23:26.183000-04:00 | |
| 1512048 | RED+BLUE STRATEGIES fdb0d803-144c-499d-8965-66ae5cd44e25 | Q1 | RED+BLUE STRATEGIES | 400693064 | EXPRESS SCRIPTS INC. | 2014 | first_quarter | PHA | H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy.Issues impacting PBMs in up coming health related legislation. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits. | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2014-04-07T15:19:16.450000-04:00 | |
| 1512856 | RED+BLUE STRATEGIES 71dbeabf-e0e1-4bcd-b73c-1f2e065da3bd | Q1 | RED+BLUE STRATEGIES | 400693064 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2014 | first_quarter | PHA | H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negative impact peoples access to prescription medications through mail. Issues related to the practice of giving coupons for certain prescription medications.CMS call letter focused on changes in policies regarding mail order and pharmacy networks. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2014-04-09T11:11:35.240000-04:00 | |
| 1513046 | MR. VINCENT A. PANVINI 86d82cbe-8f69-434d-82ad-9b6be3e0f65d | Q1 | MR. VINCENT A. PANVINI | 401008845 | PHRMA | 2014 | first_quarter | PHA | TRANSPACIFIC PARTNERSHIP, MEDICARE PART D | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2014-04-09T14:14:30.177000-04:00 | ||
| 1513072 | MR. VINCENT A. PANVINI f0d1adc1-67b9-4659-b970-227fe279c007 | Q1 | MR. VINCENT A. PANVINI | 401008845 | ELI LILLY AND COMPANY | 2014 | first_quarter | PHA | TransPacific Partnership, Medicare Part D Rebates | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2014-04-09T14:24:39.167000-04:00 | ||
| 1513270 | THORSEN FRENCH ADVOCACY LLC fdb93c96-9c46-4661-a789-08333b0a540c | Q1 | THORSEN FRENCH ADVOCACY LLC | 400599826 | ASTRAZENECA PHARMACEUTICALS LP | 2014 | first_quarter | PHA | Issues related to access to pharmaceuticals. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-10T09:48:45.607000-04:00 | |
| 1513318 | UNIVERSITY OF IOWA db2378b5-fba9-49a5-b463-d076a3461aee | Q1 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2014 | first_quarter | PHA | Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development Human factors research related to neuropharmaceuticals | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT) | 85562 | 0 | 0 | 2014-04-10T10:24:07.750000-04:00 | |
| 1513339 | RED+BLUE STRATEGIES eba8803a-6509-4ac6-b84e-053ed14c950b | Q1 | RED+BLUE STRATEGIES | 400693064 | PEW CHARITABLE TRUSTS | 2014 | first_quarter | PHA | Issues related to continuing to increase the supply of new and innovative antibiotics that will help to treat the myriad antibiotic resistant strains of bugs like MRSA. H.R. 3742 - Antibiotic Development to Advance Patient Treatment Act - focused on reinvigorating the pipeline for new antibiotics. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2014-04-10T10:25:08.967000-04:00 | |
| 1513402 | THE MATHIS HARPLE GROUP 31e180be-dcf3-4618-b226-8fc959cad1ce | Q1 | THE MATHIS HARPLE GROUP | 322911 | PILMA | 2014 | first_quarter | PHA | Medicare Pt D rebates, TransPacific Partnership | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2014-04-10T11:51:24.510000-04:00 | |
| 1513521 | ABRAHAM & ROETZEL, LLC 224c0c22-f425-4ff1-bed9-d9bc7ee5adc1 | Q1 | ABRAHAM & ROETZEL, LLC | 400954757 | MATCHRX | 2014 | first_quarter | PHA | Drug Quality and Security Act. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2014-04-10T13:53:26.870000-04:00 | |
| 1513683 | STANTON PARK GROUP 0b0d504b-8b10-4e30-9e2c-3d98a1cc934f | 1T | STANTON PARK GROUP | 83717 | ALKERMES, INC. | 2014 | first_quarter | PHA | increasing acceptance of medication assisted therapy in treating abuse of alcohol and opioid dependence | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2014-04-10T16:18:34.387000-04:00 | ||
| 1513898 | THE WALTER GROUP ead87b6a-7f1e-4a37-a0e3-f957680d972c | Q1 | THE WALTER GROUP | 309537 | AMERISOURCEBERGEN | 2014 | first_quarter | PHA | H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1416 Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R. 1919, H.R. 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding. Legislation pertaining to drug manufacturing shortages. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2014-04-11T10:19:00.867000-04:00 | |
| 1514185 | ANIMAL HEALTH INSTITUTE 5d1c9c26-7cb6-45c2-9960-8891dcdf4271 | Q1 | ANIMAL HEALTH INSTITUTE | 4037 | ANIMAL HEALTH INSTITUTE | 2014 | first_quarter | PHA | Issues related to illegal drug manufacturing under the guise of compounding. | HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR) | 30000 | 0 | 0 | 2014-04-11T13:54:34.147000-04:00 | |
| 1514241 | INDEPENDENT PHARMACY COOPERATIVE 7e230d40-51ab-4373-9088-00a0362a791a | Q1 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2014 | first_quarter | PHA | CMS Proposed Program Changes for Medicare Advantage and Prescription Drug Benefit Program for Conract Year 2015-Support Changes to Preferred Networks, Mail Order Prescriptions and MTM Services. | Centers For Medicare and Medicaid Services (CMS),SENATE | 0 | 0 | 2014-04-11T14:15:50.657000-04:00 | ||
| 1514364 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 019d33fd-0de1-4d32-a042-1ec651d7b263 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2014 | first_quarter | PHA | Issues related to anti-epileptic drugs. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2014-04-11T15:47:44.800000-04:00 | |
| 1514383 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. fcc30e29-5c19-4ede-bb88-98d6ad938fba | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2014 | first_quarter | PHA | Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 460 - Patients Access to Treatment Act | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 50000 | 0 | 0 | 2014-04-11T16:05:51.060000-04:00 | |
| 1514388 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c1948a21-faeb-424a-8c7b-8039e6df1609 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | THE HEMOPHILIA ALLIANCE | 2014 | first_quarter | PHA | ssues realted to the 340B drug discount program. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-11T16:06:51.683000-04:00 | |
| 1515170 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 22d648d9-7019-4806-b1c5-d463cfd8b533 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2014 | first_quarter | PHA | Issues related to drug shortages. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2014-04-14T14:13:35.250000-04:00 | |
| 1515520 | RUBICON ADVISORS, LLC 6b683605-c1f0-4b30-aa3c-98826c7465a5 | Q1 | RUBICON ADVISORS, LLC | 315091 | TEVA PHARMACEUTICALS USA | 2014 | first_quarter | PHA | Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 105000 | 0 | 0 | 2014-04-14T15:29:30.937000-04:00 | |
| 1515531 | RUBICON ADVISORS, LLC 81ba914d-aecb-44f8-9443-d0ca7d55572b | Q1 | RUBICON ADVISORS, LLC | 315091 | DYNAVAX TECHNOLOGIES | 2014 | first_quarter | PHA | Food and Drug Administration - Vaccines | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2014-04-14T15:37:35.653000-04:00 | |
| 1515567 | RUBICON ADVISORS, LLC 20387932-f5b1-4b2f-bc33-0ba2c2de9642 | Q1 | RUBICON ADVISORS, LLC | 315091 | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2014 | first_quarter | PHA | Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-14T15:48:44.437000-04:00 | |
| 1515570 | RUBICON ADVISORS, LLC bdd4779c-f2cd-42ab-a7ca-48e82c7b35b8 | Q1 | RUBICON ADVISORS, LLC | 315091 | ALLIANCE TO PREVENT THE ABUSE OF MEDICINES | 2014 | first_quarter | PHA | Prescription Drug Abuse Police | HOUSE OF REPRESENTATIVES,SENATE | 52500 | 0 | 0 | 2014-04-14T15:52:46.030000-04:00 | |
| 1515619 | TAUZIN CONSULTANTS, LLC 9b830f4e-80fd-4774-950f-b09b6759e074 | Q1 | TAUZIN CONSULTANTS, LLC | 400671007 | PILLGUARD MEDICATION DELIVERY SYSTEMS | 2014 | first_quarter | PHA | Building awareness of and support for the PillGuard Medication Delivery System as a tool for medication adherence and prescription drug abuse prevention. | HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2014-04-14T16:07:18-04:00 | |
| 1515812 | CHAMBER HILL STRATEGIES 93eadd56-2bd5-49bc-a4c0-f9f5063f0c6c | Q1 | CHAMBER HILL STRATEGIES | 400645947 | AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL) | 2014 | first_quarter | PHA | Implementation issues related to P.L. 113-54, the Drug Quality and Security Act | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2014-04-14T17:31:57.123000-04:00 | |
| 1515847 | VENABLE LLP f07a4467-26aa-4dd8-9654-5da12c3c8ebb | Q1 | VENABLE LLP | 39941 | ENDO PHARMACEUTICALS INC | 2014 | first_quarter | PHA | Issues related to bioequivalence and related administrative procedures; issues related to prescription drug abuse; issues related to the labeling of generic drugs. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-14T18:23:07.950000-04:00 | |
| 1515885 | DELAHUNT GROUP, LLC 2b395064-06f3-4fc7-a4f8-42411e51bb57 | Q1 | DELAHUNT GROUP, LLC | 401066001 | HEALIANCE PHARMACEUTICALS | 2014 | first_quarter | PHA | innovative diabetes treatment. | HOUSE OF REPRESENTATIVES,Natl Security Agency (NSA),SENATE,State, Dept of (DOS),Treasury, Dept of | 45000 | 0 | 0 | 2014-04-14T23:57:17.060000-04:00 | |
| 1516079 | BROWN RUDNICK LLP b1df4802-0b58-47d1-9bda-57a3f63e82e7 | Q1 | BROWN RUDNICK LLP | 287895 | APOTEX CORPORATION | 2014 | first_quarter | PHA | Issues relating to Risk Evaluation and Mitigation Strategies; Drug Quality and Security Act ( P.L. 113-54); FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (RIN:0910-AG94). | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2014-04-15T10:31:23.683000-04:00 | |
| 1516130 | ROCK & ASSOCIATES f792ec5c-3008-4018-9825-0f7345870290 | Q1 | ROCK & ASSOCIATES | 33545 | BRAIDWOOD MANAGEMENT, INC. | 2014 | first_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2014-04-15T10:37:36.823000-04:00 | |
| 1516161 | BROWN RUDNICK LLP 914bbe5c-9746-47d6-80a9-0051b9002b45 | Q1 | BROWN RUDNICK LLP | 287895 | PRIME THERAPEUTICS | 2014 | first_quarter | PHA | Issues relating to generic pharmaceutical utilization | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-15T10:44:50.013000-04:00 | |
| 1516227 | ROCK & ASSOCIATES e05c688a-7a08-4d87-ace6-556c5e873971 | Q1 | ROCK & ASSOCIATES | 33545 | CAPITOL HILL CONSULTING GROUP (ON BEHALF OF WELLNESS PHARMACY) | 2014 | first_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2014-04-15T10:53:13.137000-04:00 | ||
| 1516271 | ROCK & ASSOCIATES e780d2dc-8928-4b78-9932-eebddd2eab9a | Q1 | ROCK & ASSOCIATES | 33545 | DIAMONDBACK DRUGS | 2014 | first_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2014-04-15T11:03:32.543000-04:00 | |
| 1516312 | ROCK & ASSOCIATES 3d0a8656-b467-4d87-8bda-b1c18be6c83d | Q1 | ROCK & ASSOCIATES | 33545 | US COMPOUNDING | 2014 | first_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2014-04-15T11:15:45.903000-04:00 | |
| 1516330 | ROCK & ASSOCIATES e9d0d74f-0cf2-4cdb-bb93-bd97404f0ddd | Q1 | ROCK & ASSOCIATES | 33545 | VETERINARY PHARMACIES OF AMERICA, INC. | 2014 | first_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2014-04-15T11:25:53.823000-04:00 | |
| 1516341 | THE PROCTER AND GAMBLE COMPANY b49cbf2b-171c-4eac-8bdf-803d6c1eb90f | Q1 | THE PROCTER AND GAMBLE COMPANY | 32225 | THE PROCTER AND GAMBLE COMPANY | 2014 | first_quarter | PHA | Dextromethorphan Abuse Reduction; Regulation of OTC drugs, devices and cosmetics; S.644, Preventing Abuse of Cough Treatments Act of 2013; HR 3969, Preventing Abuse of Cough Treatments Act of 2013; S.2141, The Sunscreen Innovation Act; HR 4250, The Sunscreen Innovation Act | Bureau of Citizenship & Immigration Services (BCIS),Commerce, Dept of (DOC),Commodity Futures Trading Commission (CFTC),Consumer Product Safety Commission (CPSC),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Justice, Dept of (DOJ),Natl Security Council (NSC),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Customs & Border Protection,U.S. Immigration & Customs Enforcement (ICE),U.S. International Trade Commission (ITC),U.S. Trade Representative (USTR) | 1094205 | 0 | 0 | 2014-04-15T11:29:57.590000-04:00 | |
| 1516374 | ROCK & ASSOCIATES 61fcb1d6-4b11-4270-81b7-de821ca4138b | Q1 | ROCK & ASSOCIATES | 33545 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2014 | first_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2014-04-15T11:34:04.230000-04:00 | |
| 1516421 | ROCK & ASSOCIATES 4915c8e5-15d7-4372-9e96-4d8082ff7458 | Q1 | ROCK & ASSOCIATES | 33545 | WOMEN'S INTERNATIONAL PHARMACY | 2014 | first_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2014-04-15T11:43:17.013000-04:00 | |
| 1516930 | CAPITOL COUNSEL LLC ca65e24d-7ab4-43ae-86f4-327538e21806 | Q1 | CAPITOL COUNSEL LLC | 313715 | AMERICAN HEALTH CARE ASSOCIATION | 2014 | first_quarter | PHA | S.1560: Nursing Home Resident Pain Relief Act of 2011. S.3604: Improving Dementia Care Treatment for Older Adults Act of 2012. S.621: Safe Prescribing Act. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2014-04-15T14:59:57.683000-04:00 | |
| 1516974 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 02b5f36e-0482-415e-a135-73f18cfecf19 | Q1 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 27478 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 2014 | first_quarter | PHA | Fairness for Small Pharmacies in Part D Preferred Networks; Lifting Prohibition for Home Delivery of Diabetes Testing Supplies Home Delivery (H.R. 2845/S. 1935) ; S.644- The Preventing Abuse of Cough Treatments Act of 2013; H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013;H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; TRICARE Pharmacy Benefit/Provisions; Medicaid Reimbursement Cuts; PBM audit and generic pricing transparency and pricing reform; S. 867 - Medicare Prescription Drug Program Integrity and Transparency Act of 2013; CMS proposed rule on Medicare Part D; H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013; H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54. | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE | 420000 | 0 | 0 | 2014-04-15T15:14:06.387000-04:00 | |
| 1517186 | PARRY, ROMANI, DECONCINI & SYMMS 0ae2543b-f3cd-4988-957e-f86630d8a7de | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | POZEN, INC. | 2014 | first_quarter | PHA | Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development. | HOUSE OF REPRESENTATIVES,SENATE | 36000 | 0 | 0 | 2014-04-15T16:16:55.450000-04:00 | |
| 1517239 | CAPITOL HILL CONSULTING GROUP ffbaeccc-b50a-440c-9f22-f60443745712 | Q1 | CAPITOL HILL CONSULTING GROUP | 72053 | PROFESSIONAL COMPOUNDING CENTERS OF AMERICA | 2014 | first_quarter | PHA | Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2014-04-15T16:35:12.560000-04:00 | |
| 1517262 | CAPITOL HILL CONSULTING GROUP 3bd6e2d3-356f-4804-8230-4e1a90163574 | Q1 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2014 | first_quarter | PHA | Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2014-04-15T16:44:22.467000-04:00 | |
| 1517297 | CAPITOL HILL CONSULTING GROUP e4cb23fb-a0a2-4e30-8dec-d1eef651fa62 | Q1 | CAPITOL HILL CONSULTING GROUP | 72053 | WELLNESS PHARMACY | 2014 | first_quarter | PHA | Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2014-04-15T16:54:33.480000-04:00 | |
| 1517320 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 712ff2d4-64d7-41a6-8662-dc2e29b92997 | Q1 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 29403 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2014 | first_quarter | PHA | PseudoephedrinePseudoephedrine - potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Potential legislation to grant additional authority to the Drug Enforcement Administration (DEA) to grant exemptions to the provisions of the Combat Methamphetamine Epidemic Act of 2005 (P.L. 109-177); no bill number. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE | 0 | 0 | 2014-04-15T17:00:37.513000-04:00 | ||
| 1517405 | FLYNN & ASSOCIATES, INC. 0589e0e6-0c8c-41d7-b40f-a430c952a4ab | Q1 | FLYNN & ASSOCIATES, INC. | 15020 | PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION | 2014 | first_quarter | PHA | Medicare Part-D rebates | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2014-04-15T18:24:01.230000-04:00 | |
| 1517420 | OREGON HEALTH & SCIENCE UNIVERSITY 8f902d1b-474f-48ea-8d33-9d8c996e666f | Q1 | OREGON HEALTH & SCIENCE UNIVERSITY | 30291 | OREGON HEALTH & SCIENCE UNIVERSITY | 2014 | first_quarter | PHA | 340b Drug Discount Program for safety net hospitals | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2014-04-15T19:35:05.380000-04:00 | |
| 1517941 | CAPITOL HILL CONSULTING GROUP e487685a-b0fe-426d-ac66-2158a50b8449 | Q1 | CAPITOL HILL CONSULTING GROUP | 72053 | ROCK & ASSOCIATES | 2014 | first_quarter | PHA | Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act | HOUSE OF REPRESENTATIVES,SENATE | 28000 | 0 | 0 | 2014-04-16T10:08:13.337000-04:00 | |
| 1517979 | MASON CONSULTING, LLC 038c1c3c-8334-46a5-aabf-e7f324a51849 | Q1 | MASON CONSULTING, LLC | 400660986 | NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS | 2014 | first_quarter | PHA | Legislation and policies relating to: FDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substance H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding Americas Pharmaceuticals Act S. 621 - Safe Prescribing Act S. 959 - Pharmaceutical Compounding Quality and Accountability Act H.R. 3089 - Compounding Clarity Act H.R. 3204 - Drug Quality and Security Act (Public Law 113-54) H.R 4069 - Ensuring Patient Access and Effective Drug Enforcement Act | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,White House Office | 23450 | 0 | 0 | 2014-04-16T10:14:16.507000-04:00 | |
| 1518039 | GREATER NEW YORK HOSPITAL ASSOCIATION 4d86fe47-7c0d-42f7-963f-f71a81512cf9 | Q1 | GREATER NEW YORK HOSPITAL ASSOCIATION | 16830 | GREATER NEW YORK HOSPITAL ASSOCIATION | 2014 | first_quarter | PHA | Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L. 112-144, medical device pricing and tax issues (including gag clauses), and preserving access to group purchasing organizations (GPOs); 340b HRSA guidance on the GPO exclusion (HRSA Release 2013-1); FDA mobile health guidance and regulatory risk-based framework (FDA-2011-D-0530 andFDA-2014-N-0339); regulations affecting point-of-use care for glucose monitoring systems (FDA-2013-D-1445); ongoing pharmaceutical issues pertaining to drug shortages and significant price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); maximum allowable cost price transparency (CMS-4159-P). | Centers For Medicare and Medicaid Services (CMS),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),SENATE,White House Office | 260000 | 0 | 0 | 2014-04-16T10:27:44.477000-04:00 | |
| 1518327 | THE INGRAM GROUP LLC 5ac03f94-b749-4e13-885a-57d928c07195 | Q1 | THE INGRAM GROUP LLC | 400577737 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2014 | first_quarter | PHA | Issues related to pharmaceutical importation. Issues related to generic drugs. Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act, P.L. 113-54. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2014-04-16T11:26:13.193000-04:00 | |
| 1518386 | KOUNTOUPES DENHAM CARR & REID, LLC 9cfda2f4-d76c-4641-a6e1-4efcee7fa383 | Q1 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2014 | first_quarter | PHA | General issues related to over the counter pharmaceuticals, potential legislation to implement real-time, stop-sale electronic track- ing system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient common in popular cold and allergy medications, and opposition to prescription requirements. Issues relating to budget sequestration and the impact of the medical device user fee program, including H.R.2725, FDA Safety over Sequestration Act of 2013and S.1413, FDA User Fee Protection Act. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2014-04-16T11:38:32.930000-04:00 | |
| 1518496 | BLUECROSS BLUESHIELD OF TENNESSEE 4b35d439-ba25-480d-b321-bf61b65a7fa8 | Q1 | BLUECROSS BLUESHIELD OF TENNESSEE | 6440 | BLUECROSS BLUESHIELD OF TENNESSEE | 2014 | first_quarter | PHA | General Pharmacy Issues | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2014-04-16T12:09:07.337000-04:00 | |
| 1518706 | BUCHANAN INGERSOLL & ROONEY PC 4c6fb45f-cf7c-4e05-83de-cf029bd0bf5d | Q1 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION - ALA: PENNSYLVANIA BIO | 2014 | first_quarter | PHA | Life sciences, orphan drugs, medical devices, budget | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2014-04-16T12:51:51.720000-04:00 | |
| 1519102 | NOVO NORDISK INC. 93fba3cf-47d7-4313-a838-136da7c3e7fe | Q1 | NOVO NORDISK INC. | 284790 | NOVO NORDISK INC. | 2014 | first_quarter | PHA | HR 3204, S. 959 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; 340B | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Trade Representative (USTR),Veterans Affairs, Dept of (VA) | 710000 | 0 | 0 | 2014-04-16T14:21:00.957000-04:00 | |
| 1519209 | BROWN RUDNICK LLP 2419d881-784a-4aca-b5c3-9d6ce269b8cb | Q1 | BROWN RUDNICK LLP | 287895 | AMNEAL PHARMACEUTICALS | 2014 | first_quarter | PHA | Issues related to FDA rule on drug labeling; issues relating to Risk Evaluation and Mitigation Strategies; Drug Quality and Security Act ( P.L. 113-54); FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (RIN:0910-AG94). | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-16T14:34:31.833000-04:00 | |
| 1519305 | BROWN RUDNICK LLP d8433718-f870-492c-8488-2f9f95fee107 | Q1 | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2014 | first_quarter | PHA | H.R. 4069-Ensuring Patient Access and Effective Drug Enforcement Act"; Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II [NPRM Docket No. DEA-389] | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2014-04-16T14:47:57.333000-04:00 | |
| 1519438 | SCONSET STRATEGIES, LLC 755365d7-b057-4d38-ada3-fb4dc7dd832c | Q1 | SCONSET STRATEGIES, LLC | 400794388 | FREEMAN ALLERGY, INC. | 2014 | first_quarter | PHA | Meetings regarding securing clinical trials at Johns Hopkins University. Meetings regarding securing clinical trials at The Redstone Arsenal- Huntsville, Alabama. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2014-04-16T15:00:35.317000-04:00 | |
| 1519450 | BROWN RUDNICK LLP 37e37ac0-b2bb-4b9f-a2c1-ccfbb667b646 | Q1 | BROWN RUDNICK LLP | 287895 | HOSPIRA, INC. | 2014 | first_quarter | PHA | Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products) | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 50000 | 0 | 0 | 2014-04-16T15:01:39.020000-04:00 | |
| 1519729 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 548a22fa-5ec7-4d09-ae38-741293d73c05 | 1A | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 29403 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2014 | first_quarter | PHA | Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC SwitchSupporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. | HOUSE OF REPRESENTATIVES,SENATE | 320000 | 0 | 0 | 2014-04-16T15:48:05.943000-04:00 | |
| 1519943 | MR. GALEN RESER 8838a224-4e16-4376-a01d-98c8467e661a | Q1 | MR. GALEN RESER | 401055978 | PERRIGO INC (THROUGH FTI GOVERNMENT AFFAIRS) | 2014 | first_quarter | PHA | Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, H.R. 2835, "Restoring Access to Medication Act of 2013." FDA's proposed changes to generic drug labeling. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2014-04-16T16:22:52.473000-04:00 | |
| 1520189 | ACADEMY OF MANAGED CARE PHARMACY c6dbf213-efd7-44a5-8e95-da826391577e | Q1 | ACADEMY OF MANAGED CARE PHARMACY | 48793 | ACADEMY OF MANAGED CARE PHARMACY | 2014 | first_quarter | PHA | Biosimilar naming--supporting Congressional action to seek FDA decision on biosimilar naming | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 199000 | 0 | 0 | 2014-04-16T17:31:11.257000-04:00 | |
| 1520203 | EVERGREEN ASSOCIATES, LTD. 55252caf-20fc-4391-9183-0ab3996ad289 | Q1 | EVERGREEN ASSOCIATES, LTD. | 13984 | PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION | 2014 | first_quarter | PHA | - RIN: 0910-AG18, Electronic Distribution of Content Labeling for Human Prescription Drug and Biological Products - Risk Communications: Consumer Medication Information, Medication Guides, Patient Package Inserts, Professional Inserts - S. 752/H.R. 1608: Cody Miller Initiative for Safer Prescriptions Act - Department of Agriculture Appropriations Act, 2015 | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA) | 10000 | 0 | 0 | 2014-04-16T17:33:15.303000-04:00 | |
| 1520754 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 2f5d8c99-9ab8-41f0-82c6-c191abb233cd | Q1 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2014 | first_quarter | PHA | Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715) | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 267000 | 0 | 0 | 2014-04-17T09:11:50.767000-04:00 | |
| 1520802 | THE D MAJOR GROUP 71199576-299b-4448-9a27-751ca8c3f213 | Q1 | THE D MAJOR GROUP | 401103162 | ALLERGAN INC (FORMERLY ACTAVIS INC ) | 2014 | first_quarter | PHA | H.R. 3204, The Drug Quality and Security Act | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2014-04-17T09:30:00.753000-04:00 | |
| 1520821 | APOTEX CORP. df106649-58e7-48fb-a6a6-f46f8ec2f561 | Q1 | APOTEX CORP. | 310973 | APOTEX CORP. | 2014 | first_quarter | PHA | Federal policy regarding Public Law 113-54, the Drug Quality and Security Act, Title II, Drug Supply Chain Security, Section 581, Definitions, provision relating to the definition of manufacturer;Potential legislation relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing; FDA proposed rule,Supplemental Applications Proposing Labeling Changes For Approved Drugs And Biological Products, Docket Number FDA-2013-N-0500, provisions relating to generic drug labeling changes; Proposed FDA rule, "Electronic Distribution of Prescribing Information for Human Prescription Drugs Including Biological Products," RIN: 0910-AG18, provisions relating to the use of electronic package inserts for human pharmaceuticals and biologics | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 130000 | 0 | 0 | 2014-04-17T09:36:05.783000-04:00 | |
| 1520847 | THE D MAJOR GROUP d92092b5-5adb-4ca0-b4b2-bc89d913e028 | Q1 | THE D MAJOR GROUP | 401103162 | HEALTH CARE SUPPLY CHAIN ASSOCIATION | 2014 | first_quarter | PHA | H.R. 3204, The Drug Quality and Security Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-17T09:48:15.377000-04:00 | |
| 1520981 | THE D MAJOR GROUP 6ab5ac8c-b032-4003-b6f3-a1a99e80cf8b | Q1 | THE D MAJOR GROUP | 401103162 | CVS CAREMARK | 2014 | first_quarter | PHA | H.R. 3204, The Drug Quality and Security Act H.R. 3392, The Medicare Part D Patient Safety & Drug Abuse Prevention Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-17T10:06:48.067000-04:00 | |
| 1521170 | MCDERMOTT WILL & SCHULTE LLP b1a3f5bb-6719-48a7-8792-f6adb1578611 | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ALLERGAN, INC. | 2014 | first_quarter | PHA | Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2014-04-17T10:33:45.783000-04:00 | ||
| 1521624 | NATIONAL PATIENT ADVOCATE FOUNDATION 321a7781-2d5b-4b00-9337-12c7d2ea6d5f | Q1 | NATIONAL PATIENT ADVOCATE FOUNDATION | 28311 | NATIONAL PATIENT ADVOCATE FOUNDATION | 2014 | first_quarter | PHA | Specialty Tiers, Biosimilars, Innovation | HOUSE OF REPRESENTATIVES,SENATE | 33873 | 0 | 0 | 2014-04-17T11:20:10.017000-04:00 | |
| 1521755 | CROSSROADS STRATEGIES, LLC e2227ff2-2ca4-49f5-b9c3-383cf380a92f | Q1 | CROSSROADS STRATEGIES, LLC | 400531586 | LUMARA HEALTH | 2014 | first_quarter | PHA | Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2014-04-17T11:32:45.800000-04:00 | |
| 1522244 | FTI GOVERNMENT AFFAIRS c9d17ba7-655e-4b8c-86f4-40a566c8b770 | Q1 | FTI GOVERNMENT AFFAIRS | 401054971 | AMERICAS HEALTH INSURANCE PLANS (AHIP) | 2014 | first_quarter | PHA | H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) - FEHBP prescription drugs; H.R. 3204, Drug Quality and Security Act (Upton) - drug safety issues; S. 214, Preserve Access to Affordable Generics Act (Klobuchar) - access to generic drugs. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-17T12:56:34.300000-04:00 | |
| 1522795 | THORN RUN PARTNERS 59452f01-ad4f-4706-8844-ffb23ddba699 | Q1 | THORN RUN PARTNERS | 400534596 | INSPIRION PHARMACEUTICALS, LLC | 2014 | first_quarter | PHA | Issues related to promoting innovation in abuse-deterrent opioids. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2014-04-17T14:14:32.003000-04:00 | |
| 1522955 | STANTON PARK GROUP 6f0e1c33-eb2c-4664-9bfe-75980c5e04b4 | Q1 | STANTON PARK GROUP | 83717 | MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY) | 2014 | first_quarter | PHA | Pharmacy issues, prescription drug supply chain issues, including security of the supply chain, drug shortages, prescription drug abuse and diversion. H.R. 1919 "Safeguarding America's Pharmaceuticals Act of 2013". S. 957 "Drug Supply Chain Security Act". S. 959 "Pharmaceutical Quality, Security and Accountability Act" | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2014-04-17T14:29:26.877000-04:00 | |
| 1523012 | KOUNTOUPES DENHAM CARR & REID, LLC b071f645-2bc2-4d19-a46d-ba6967b41788 | Q1 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) | 2014 | first_quarter | PHA | Policy matters related to generic pharmaceuticals and biosimilars including naming, labeling, e-labeling, access and interchangeability. | HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 50000 | 0 | 0 | 2014-04-17T14:34:42.957000-04:00 | |
| 1523086 | SANOFI US SERVICES INC. ae211df0-4818-46dd-bfa0-e3a953a3f109 | Q1 | SANOFI US SERVICES INC. | 56838 | SANOFI US SERVICES INC | 2014 | first_quarter | PHA | General issues related to the 340B Federal Drug Pricing Program | HOUSE OF REPRESENTATIVES,SENATE | 1570000 | 0 | 0 | 2014-04-17T14:42:07.817000-04:00 | |
| 1523189 | HANCE SCARBOROUGH b28359b6-725d-45e9-876b-a67c3fde13a0 | Q1 | HANCE SCARBOROUGH | 17443 | ALLIANCE OF INDEPENDENT PHARMACISTS - TEXAS | 2014 | first_quarter | PHA | Federal legislation affecting the practice of pharmacy, and FDA and DEA regulations of compounded drugs. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2014-04-17T14:50:38.893000-04:00 | |
| 1523226 | PD FRAZER CONSULTING, INC. c3300eba-8817-43aa-a795-63b205ac0716 | Q1 | PD FRAZER CONSULTING, INC. | 65998 | CANADA INTERNATIONAL PHARMACY ASSOCIATION | 2014 | first_quarter | PHA | Monitor the development of proposed bills about the importation of prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2014-04-17T14:53:51.987000-04:00 | |
| 1523501 | EMPIRE CONSULTING GROUP da2588c2-0647-41ab-9fec-1f9da1ed02d9 | Q1 | EMPIRE CONSULTING GROUP | 400703105 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2014 | first_quarter | PHA | Issues relating to the Medicare Prescription Drug Act; H.R. 4160, Keep the Promise to Seniors Act of 2014; Budgetary issues pertaining to Medicare Part D; CMS rulemaking alterations to Medicare Part D. | HOUSE OF REPRESENTATIVES | 40000 | 0 | 0 | 2014-04-17T15:19:19.910000-04:00 | |
| 1523708 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION bc50f9eb-22d8-4c69-9b6f-9c5be8bd0edb | Q1 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 31348 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 2014 | first_quarter | PHA | Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market (essential health benefits, grandfathering, value-based insurance design, e-prescribing, PBM disclosure requirements, and medical loss ratio).Regulatory and proposed legislative changes to Medicare part D including pharmacy networks, classes of clinical concern, mail-service pharmacy, EGWP waivers, MTM expansion, long term care short-term fills, recovery audit contractors. Implementation of changes to the definition of Average Manufacturer Price in Medicaid Issues related to the management of Medicaid prescription drug benefits Legislation to promote generic drugs. Regulatory Implementation of the HITECH Act. FDA issues related to the Prescription Drug User Fee Act (PDUFA) (generic user fees, pedigree, REMs); implementation of approval pathway for generic biologic drugs, 340B program. Issues related to the compounding of certain drugs. S. 77, Prescription Drug and Health Improvement Act S. 557, Medication Therapy Management Empowerment Act H.R. 460, Patients Access to Treatments Act H.R. 1188, Preserving Our Hometown Independent Pharmacies Act H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 1024, Medication Therapy Management Empowerment Act S.867, Medicare Prescription Drug Program Integrity and Transparency Act H.R. 2960, Medicare Prescription Drug Integrity Act of 2013 H.R. 4160, Keep the Promise to Seniors Act | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE | 939936 | 0 | 0 | 2014-04-17T15:45:23.377000-04:00 | |
| 1523960 | UNIVERSITY OF CONNECTICUT 920efb9b-191b-4e3a-8e04-d4c34185b89d | Q1 | UNIVERSITY OF CONNECTICUT | 39382 | UNIVERSITY OF CONNECTICUT | 2014 | first_quarter | PHA | Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2015, Monitor FDA salaries and expense issues; and extramural research. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2014-04-17T16:05:51.180000-04:00 | |
| 1524027 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 15e52d8d-bf89-4aa9-82d2-c271f1b2954a | Q1 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2014 | first_quarter | PHA | Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the GAO on compounding. Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on labeling of generic medications and drugs containing salts. Communication with FTCon biosimilars. Support for H.R. 3742, all titles, theAntibiotic Development to Advance patient Treatment Act. | Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 250000 | 0 | 0 | 2014-04-17T16:11:07.660000-04:00 | |
| 1524216 | AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 67405579-7879-4860-8fff-8c98b5b19f7e | Q1 | AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES | 2321 | AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES | 2014 | first_quarter | PHA | Reduce prescription drug costs in Medicare/Medicaid | HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR),White House Office | 680000 | 0 | 0 | 2014-04-17T16:26:57.493000-04:00 | |
| 1524561 | CAPITOL COUNSEL LLC afe628ec-9d67-4fee-9b8c-82a88caf9b52 | 1A | CAPITOL COUNSEL LLC | 313715 | AMERICAN HEALTH CARE ASSOCIATION | 2014 | first_quarter | PHA | S.1560: Nursing Home Resident Pain Relief Act of 2011. S.3604: Improving Dementia Care Treatment for Older Adults Act of 2012. S.621: Safe Prescribing Act. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2014-04-17T17:08:35.713000-04:00 | |
| 1524570 | TARPLIN, DOWNS & YOUNG, LLC 3d6e35e9-7789-4370-a816-57e854123bb3 | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2014 | first_quarter | PHA | **see addendum pageImportation of prescription drugs (H.R. 3715) Drug Shortages (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069), Hydrocodone Rescheduling (H.R. 1285, S. 621, and NPRM Docket No. DEA-389), Dextromethorphan (S. 644) | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2014-04-17T17:09:38.603000-04:00 | |
| 1524578 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES 16e9d554-f87a-4792-a231-d66b91f831ac | Q1 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2014 | first_quarter | PHA | S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act H.R.3204 - Drug Quality and Security Act H.R. 4437 - Generic Drug Pricing Fairness Act | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 740000 | 0 | 0 | 2014-04-17T17:11:41.523000-04:00 | |
| 1524644 | GOLDEN HORIZONS fa20e643-cef4-4abc-93bc-a8706ec9fb06 | Q1 | GOLDEN HORIZONS | 44275 | GOLDEN HORIZONS | 2014 | first_quarter | PHA | Monitor and advocate regarding pharmacy issues impacting Long Term Care and Post Acute Care providers and patients. Keep the Promise to Seniors Act of 2014, H.R. 4160 | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Medicare Payment Advisory Commission (MedPAC),SENATE,Veterans Affairs, Dept of (VA) | 95997 | 0 | 0 | 2014-04-17T17:29:05.507000-04:00 | |
| 1524648 | EXPRESS SCRIPTS, INC. 65752350-7ffd-4bee-962d-d453df30be59 | Q1 | EXPRESS SCRIPTS, INC. | 294416 | EXPRESS SCRIPTS, INC. | 2014 | first_quarter | PHA | Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit design and pricing (MAC)issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act. | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Personnel Management (OPM),SENATE,White House Office | 650000 | 0 | 0 | 2014-04-17T17:30:06.727000-04:00 | |
| 1524827 | MCKENNA, LONG & ALDRIDGE 3bbae8db-f3d4-4638-b163-ed7b50b9e225 | Q1 | MCKENNA, LONG & ALDRIDGE | 76913 | PURDUE PHARMA | 2014 | first_quarter | PHA | U.S. and Canadian regulatory policies regarding prescription drug abuse. | HOUSE OF REPRESENTATIVES | 0 | 0 | 2014-04-17T18:17:47.837000-04:00 | ||
| 1525340 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 4c06b5bf-2d40-4e56-87e9-7fcb995452e0 | Q1 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 35968 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014 | first_quarter | PHA | Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (HR 3204). | Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE | 80000 | 0 | 0 | 2014-04-18T09:26:35.353000-04:00 | |
| 1525447 | WILLIAMS AND JENSEN, PLLC e919aa1c-b0bf-40f3-9596-163ea31bf305 | Q1 | WILLIAMS AND JENSEN, PLLC | 41454 | PHARMACY SERVICES | 2014 | first_quarter | PHA | Regulations of compounding pharmacies. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-18T09:43:11.727000-04:00 | |
| 1525486 | ELI LILLY AND COMPANY 3e3af76b-8a58-4088-bbcc-b40c057f8d65 | Q1 | ELI LILLY AND COMPANY | 13392 | ELI LILLY AND COMPANY | 2014 | first_quarter | PHA | Hospital discounts (HR 3590) | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR) | 2086000 | 0 | 0 | 2014-04-18T09:46:23.477000-04:00 | |
| 1525501 | FORBES-TATE fe72cb6d-a012-4391-9d5d-f72f86ecc696 | 1T | FORBES-TATE | 400976792 | MERCK | 2014 | first_quarter | PHA | Issues related to pharmaceutical drug safety track and trace program legislation. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 1 | 2014-04-18T09:48:26.743000-04:00 | |
| 1525744 | AMERICAN COLLEGE OF EMERGENCY PHYSICIANS 9dd3d0a3-82fb-441b-a838-ae1d7779c643 | Q1 | AMERICAN COLLEGE OF EMERGENCY PHYSICIANS | 1967 | AMERICAN COLLEGE OF EMERGENCY PHYSICIANS | 2014 | first_quarter | PHA | H.R.3089-Compounding Clarity Act H.R.3528-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2013 S.1323-Protecting Our Youth from Dangerous Synthetic Drugs Act of 2013 | HOUSE OF REPRESENTATIVES,SENATE | 538612 | 0 | 0 | 2014-04-18T10:25:41.657000-04:00 | |
| 1525764 | FAEGRE BAKER DANIELS CONSULTING 93dc599d-9ac6-4f07-9818-75ee66f3c72e | Q1 | FAEGRE BAKER DANIELS CONSULTING | 34158 | PAPCC COALITION | 2014 | first_quarter | PHA | Medicare policy | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2014-04-18T10:29:44.433000-04:00 | |
| 1525777 | ALLERGAN USA, INC. e39c8227-c026-49d2-b5b3-138369812bbe | Q1 | ALLERGAN USA, INC. | 63837 | ALLERGAN USA, INC. | 2014 | first_quarter | PHA | Drug Labeling | Federal Communications Commission (FCC),HOUSE OF REPRESENTATIVES,SENATE | 420000 | 0 | 0 | 2014-04-18T10:30:34.387000-04:00 | |
| 1525860 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. 64bf1251-7221-4a15-a1cc-a94bd3093e4e | Q1 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. | 4653 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. | 2014 | first_quarter | PHA | Proposals relating to the regulation of direct to consumer prescription drug advertising FDA proposal relating to disclosure of side effects in television advertisements | Commerce, Dept of (DOC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),Office of Science & Technology Policy (OSTP),SENATE | 380000 | 0 | 0 | 2014-04-18T10:38:20.353000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);